treated group

DRUG4 trials

Sponsors

Hôpital NOVO, Second Affiliated Hospital of Wenzhou Medical University, HDC laboratory, none

Conditions

Gestational DiabetesHistiocytosis, Langerhans-CellRespiratoryenlarged pore enlarged pore Erbium:YAG laser

Phase 1

Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents

Enrolling by invitationNCT06902792

Second Affiliated Hospital of Wenzhou Medical UniversityHistiocytosis, Langerhans-Cell

Start: 2025-02-06End: 2026-02-02Target: 6Updated: 2025-03-30

Phase 3

Quercetin as an antiviral agent against Coronavirus infection: Double blind clinical trial

Active, not recruitingPACTR202406512501178

HDC laboratoryRespiratory

Start: 2021-05-01Target: 244Updated: 2026-09-14

Unknown Phase

The efficacy and safety of Erbium:YAG laser for treatment of enlarged pores: a pilot study

Active, not recruitingTCTR20170410001

noneenlarged pore enlarged pore Erbium:YAG laser

Start: 2015-04-09Updated: 2026-08-03

MyDiabby Healthcare Vs Diary in Gestational Diabetes Mellitus.

CompletedNCT05510583

Hôpital NOVOGestational Diabetes

Start: 2022-08-02End: 2023-04-17Updated: 2024-09-19